Rise in Dog Bites Driving Market Growth: Key Driver Transforming Anti-Rabies Serum 2025

The Business Research Company's Anti-Rabies Serum Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, February 11, 2025 /EINPresswire.com/ -- The Anti Rabies Serum market projected a substantial increase from $1.42 billion in 2024 to $1.5 billion in 2025, marking an impressive compound annual growth rate CAGR of 5.7%. The report emphasizes an array of factors contributing to this impressive trajectory, including marked growth in animal populations, the expansion of vaccination programs, tech-advancements in diagnostic techniques, and rising public health initiatives. As per predictions, the trend will not only sustain but also amplify with the market size expected to hit $1.85 billion by 2029 at a CAGR of 5.4%.

What's Driving this Sustained Growth?

The surge in the prevalence of dog bites stands out as a significant propellant catalyzing the growth of the anti-rabies serum market. Dog bites, varying from minor to severe, precipitate infections, high-risk wounds, and in certain cases, even the transmission of diseases such as rabies. As urbanization takes hold leading to higher interactions between people and dogs coupled with a increase in the number of unrestrained or poorly-trained dogs, the prevalence of dog bites is experiencing a notable uptick.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp

What major factors are shaping the market?

The market size is significantly bolstered by the rising incidence of animal bites, increased funding for rabies research, and the burgeoning awareness of zoonotic diseases. Also, facilitating this growth is the marked developments such as improved serum storage and handling, enhanced support for rabies control programs, and technological advances in serum production. Other notable factors include the development of alternative delivery systems, and the creation of rapid diagnostic kits.

Who are the key players?

The anti-rabies serum market is dominated by key names such as Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, and many more. These players are focused on strategic partnerships to strengthen product development and widen market reach. For instance, in July 2023, Kedrion S.p.A partered with Kamada, an Israel-based biopharmaceutical company to distribute KEDRAB Rabies Immune Globulin Human in the US. This collaboration proved crucial in co-developing and licensing the product in the U.S., while also fostering disease awareness.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report

How is the market segmented?

The anti-rabies serum market delineates into different segments:

1 By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2 By Dosage And Form: Vials, Prefilled Syringes
3 By Route of Administration: Intravenous, Intramuscular
4 By End User: Hospitals, Clinics, Veterinary Hospitals

Focusing on the regional outlook, North America has emerged as the dominant region in the anti-rabies serum market in 2024. However, the spectrum of the market is global, extending over Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Discover More Similar Reports By The Business Research Company

Rabies Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Anti-Inflammatory Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

The Business Research Company, with its repository of over 15000+ reports across 27 industries covering 60+ geographies, stands out as a comprehensive resource of data-rich research and insights. Equipped with 1,500,000 datasets, the synergy of in-depth secondary research, and unique inputs from industry leaders, we are poised to offer the information you need to stay at the top of your game. Contact us today!

The Business Research Company:
https://www.thebusinessresearchcompany.com/

Americas: +1 3156230293
Asia: +44 2071930708
Europe: +44 2071930708
Email: info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn